New research led by King’s College London, in collaboration with the University of Westminster, has shed light on the diversity and characteristics of E. coli strains that drive diabetic foot infections.

Acta Pharmaceutica Sinica B Volume 15, Issue 12 Publishes

The American Cancer Society today released its annual “Cancer Statistics, 2026” and “Cancer Facts & Figures 2026” report — the first national snapshot of this year’s cancer trends. Experts from City of Hope^®, one of the country’s leading cancer research and treatment institutions, are available immediately for interviews to help interpret key trends and provide context for how these findings affect patients, families and the future of cancer care. We also have patients available for interviews.

https://doi.org/10.1016/j.apsb.2025.08.017

This new article publication from Acta Pharmaceutica Sinica B, discusses how RDYH58 functional exosomes target myofibroblasts loaded with siFKBP10 for the inhibition of collagen biosynthesis and secretion of IPF.

https://doi.org/10.1016/j.apsb.2025.09.009

This new article publication from Acta Pharmaceutica Sinica B, discusses rational engineering of degradation tail-driven CELMoD–antibody conjugates for precision malignancy therapy.

https://doi.org/10.1016/j.apsb.2025.10.029

This new article publication from Acta Pharmaceutica Sinica B, discusses probiotic living microneedles designed by interbacterial competition for accelerated infected wound healing.

https://doi.org/10.1016/j.apsb.2025.08.006

This new article publication from Acta Pharmaceutica Sinica B, discusses how key imidazolyl groups that induce phenylalanine flipping enhance the efficacy of oral BRD9 inhibitors for AML treatment.

https://doi.org/10.1016/j.apsb.2025.09.030

This new article publication from Acta Pharmaceutica Sinica B, discusses injectable hydrogel-mediated co-delivery of oncolytic adenovirus and melphalan for retinoblastoma control and vision preservation.